Paris, France – September 6, 2016 – Sanofi announces that it has successfully priced its offering of EUR 3 billion of notes across 3 tranches:
- EUR 1.0 billion Fixed Rate Notes, due January 2020, bearing interest at an annual rate of 0.0%
- EUR 0.85 billion Fixed Rate Notes, due September 2022, bearing interest at an annual rate of 0.0%
- EUR 1.15 billion Fixed Rate Notes, due January 2027, bearing interest at an annual rate of 0.5%
The issue is drawn under the Company’s Euro Medium Term Note Programme.
The transaction enables the Company to lower its average cost of debt and extend the average maturity of its debt.
Sanofi intends to use the net proceeds of the offering for general corporate purposes.
BNP Paribas and Morgan Stanley acted as Global Coordinators and Bookrunners, alongside Crédit Agricole CIB, Deutsche Bank, MUFG and Natixis which acted as Bookrunners for the offering.